Exact Mass: 315.07765420000004

Exact Mass Matches: 315.07765420000004

Found 84 metabolites which its exact mass value is equals to given mass value 315.07765420000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Chlorprothixene

[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]dimethylamine

C18H18ClNS (315.08484180000005)


Chlorprothixene is only found in individuals that have used or taken this drug. It is a typical antipsychotic drug of the thioxanthene (tricyclic) class. Chlorprothixene exerts strong blocking effects by blocking the 5-HT2 D1, D2, D3, histamine H1, muscarinic and alpha1 adrenergic receptors. Chlorprothixene blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Chlorprothixene is a dopamine and histamine receptors antagonist with Kis of 18 nM, 2.96 nM, 4.56 nM, 9 nM and 3.75 nM for hD1, hD2, hD3, hD5 and hH1 receptors, respectively. Antipsychotic activity[1].

   

Rosinidin

Rosinidin

C17H15O6+ (315.086859)


An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 5, a methoxy group at position 7 and a 4-hydroxy-3-methoxyphenyl group at position 2.

   

Oxfendazole

Oxfendazole

C15H13N3O3S (315.06775880000004)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3672; ORIGINAL_PRECURSOR_SCAN_NO 3670 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3663; ORIGINAL_PRECURSOR_SCAN_NO 3660 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3677; ORIGINAL_PRECURSOR_SCAN_NO 3673 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3666; ORIGINAL_PRECURSOR_SCAN_NO 3662 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3739; ORIGINAL_PRECURSOR_SCAN_NO 3736 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3676; ORIGINAL_PRECURSOR_SCAN_NO 3674 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7569; ORIGINAL_PRECURSOR_SCAN_NO 7565 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7593; ORIGINAL_PRECURSOR_SCAN_NO 7591 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7621; ORIGINAL_PRECURSOR_SCAN_NO 7619 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7615; ORIGINAL_PRECURSOR_SCAN_NO 7613 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7596; ORIGINAL_PRECURSOR_SCAN_NO 7593 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7629; ORIGINAL_PRECURSOR_SCAN_NO 7627 CONFIDENCE standard compound; INTERNAL_ID 1165 CONFIDENCE standard compound; INTERNAL_ID 1065

   
   

Oxfendazole

(5-(Phenylsulphinyl)-1H-benzimidazol-2-yl)carbamic acid methyl ester

C15H13N3O3S (315.06775880000004)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Anthelmintic, used in cattle, sheep and horse

   

Avenanthramide C

2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoate

C16H13NO6 (315.0742838)


Avenanthramide c is a member of the class of compounds known as avenanthramides. Avenanthramides are a group of phenolic alkaloids consisting of conjugate of three phenylpropanoids (ferulic, caffeic, or p-coumaric acid) and anthranilic acid. Avenanthramide c is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Avenanthramide c can be found in cereals and cereal products, which makes avenanthramide c a potential biomarker for the consumption of this food product. N-(3,4-Dihydroxycinnamoyl)-2-amino-5-hydroxybenzoic acid is found in cereals and cereal products. N-(3,4-Dihydroxycinnamoyl)-2-amino-5-hydroxybenzoic acid is isolated from oats (Avena sativa).

   

4-Hydroxyfenbendazole

methyl N-{5-[(4-hydroxyphenyl)sulfanyl]-3H-1,3-benzodiazol-2-yl}carbamate

C15H13N3O3S (315.06775880000004)


   

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine

C16H14ClN3O2 (315.0774494)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors

   

Fotemustina

diethyl {1-[N-(2-chloroethyl)-N-nitroso-(C-hydroxycarbonimidoyl)amino]ethyl}phosphonate

C9H19ClN3O5P (315.0750804)


   

N-(3',4'-Dihydroxycinnamoyl)-5-hydroxyanthranilic acid

2-{[3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoate

C16H13NO6 (315.0742838)


   

Phosphonate analog

{5-[(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)methyl]oxolan-2-yl}phosphonate

C10H14N5O5P (315.07325240000006)


   

TrkA Inhibitor

4-{[(2-hydroxy-1H-indol-3-yl)methylidene]amino}benzene-1-sulphonamide

C15H13N3O3S (315.06775880000004)


   

Avenanthramide K

2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-4-hydroxybenzoate

C16H13NO6 (315.0742838)


Avenanthramide k is a member of the class of compounds known as avenanthramides. Avenanthramides are a group of phenolic alkaloids consisting of conjugate of three phenylpropanoids (ferulic, caffeic, or p-coumaric acid) and anthranilic acid. Avenanthramide k is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Avenanthramide k can be found in oat, which makes avenanthramide k a potential biomarker for the consumption of this food product.

   
   

Rosinidin

3,5,4-Trihydroxy-7,3-dimethoxyflavylium

C17H15O6 (315.086859)


   

AG-1478

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine

C16H14ClN3O2 (315.0774494)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors

   
   

chlorprothixene

chlorprothixene

C18H18ClNS (315.08484180000005)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Chlorprothixene is a dopamine and histamine receptors antagonist with Kis of 18 nM, 2.96 nM, 4.56 nM, 9 nM and 3.75 nM for hD1, hD2, hD3, hD5 and hH1 receptors, respectively. Antipsychotic activity[1].

   

p-[N-Propyl-N-(2-carboxyethyl)sulfamoyl]benzoic acid

p-[N-Propyl-N-(2-carboxyethyl)sulfamoyl]benzoic acid

C13H17NO6S (315.07765420000004)


   

S-NEPC

4-nitrophenyl-2S,3S-epoxy-3 phenylpropyl carbonate

C16H13NO6 (315.0742838)


   

Avenanthramide C

2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enamido]-5-hydroxybenzoic acid

C16H13NO6 (315.0742838)


   

Sulfamide,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-

Sulfamide,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-

C12H17N3O3S2 (315.07112920000003)


   

3-[[2-(4-carboxyphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-carboxyphenoxy)acetyl]amino]benzoic acid

C16H13NO6 (315.0742838)


   

3-[[2-(1,3-benzodioxol-5-yloxy)acetyl]amino]benzoic acid

3-[[2-(1,3-benzodioxol-5-yloxy)acetyl]amino]benzoic acid

C16H13NO6 (315.0742838)


   

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanone

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanone

C18H12F3NO (315.0870938)


   

2-quinolin-2-yl-1-[3-(trifluoromethyl)phenyl]ethanone

2-quinolin-2-yl-1-[3-(trifluoromethyl)phenyl]ethanone

C18H12F3NO (315.0870938)


   

Fotemustine

Fotemustine

C9H19ClN3O5P (315.0750804)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AD - Nitrosoureas C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

(R)-(-)-n-(3,5-dinitrobenzoyl)-alpha-phenylethylamine

(R)-(-)-n-(3,5-dinitrobenzoyl)-alpha-phenylethylamine

C15H13N3O5 (315.0855168)


   

2-[4-(2-pyrimidinyl)-1-piperazinyl]ethanamine(SALTDATA: 3HCl)

2-[4-(2-pyrimidinyl)-1-piperazinyl]ethanamine(SALTDATA: 3HCl)

C10H20Cl3N5 (315.07842100000005)


   

ETHYL 2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

ETHYL 2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

C16H14ClN3O2 (315.0774494)


   

6-[Methyl(propyl)amino]-5,6,7,8-tetrahydro-2,3-naphthalenediol hy drobromide (1:1)

6-[Methyl(propyl)amino]-5,6,7,8-tetrahydro-2,3-naphthalenediol hy drobromide (1:1)

C14H22BrNO2 (315.0833812)


   

ethyl 4-chloro-5-methyl-7-phenylpyrrolo[2,3-d]pyrimidine-6-carboxylate

ethyl 4-chloro-5-methyl-7-phenylpyrrolo[2,3-d]pyrimidine-6-carboxylate

C16H14ClN3O2 (315.0774494)


   

2-CYANO-2-(3-ETHYL-4-OXO-5-((PHENYLAMINO)METHYLENE)THIAZOLIDIN-2-YLIDENE)ACETIC ACID

2-CYANO-2-(3-ETHYL-4-OXO-5-((PHENYLAMINO)METHYLENE)THIAZOLIDIN-2-YLIDENE)ACETIC ACID

C15H13N3O3S (315.06775880000004)


   

N-(p-Toluenesulfonyl)indole-3-boronic acid

N-(p-Toluenesulfonyl)indole-3-boronic acid

C15H14BNO4S (315.07365540000006)


   

5-METHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRAZOL-3-YL 2-CHLORONICOTINATE

5-METHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRAZOL-3-YL 2-CHLORONICOTINATE

C16H14ClN3O2 (315.0774494)


   

boc-3-chloro-l-tyrosine

boc-3-chloro-l-tyrosine

C14H18ClNO5 (315.0873448)


   

1-(benzenesulfonyl)indole-2-carbohydrazide

1-(benzenesulfonyl)indole-2-carbohydrazide

C15H13N3O3S (315.06775880000004)


   

4-Chloro-2-(piperazin-1-yl)-6-(trifluoromethyl)quinoline

4-Chloro-2-(piperazin-1-yl)-6-(trifluoromethyl)quinoline

C14H13ClF3N3 (315.0750044)


   

(S)-(+)-CROTONYLCYCLOPENTANEDIENYLIRONCARBONYLTRIPHENYLPHOSPHINECOMPLEX

(S)-(+)-CROTONYLCYCLOPENTANEDIENYLIRONCARBONYLTRIPHENYLPHOSPHINECOMPLEX

C15H13N3O5 (315.0855168)


   

b-Alanine,N-(2-carboxyethyl)-N-[(4-methylphenyl)sulfonyl]-

b-Alanine,N-(2-carboxyethyl)-N-[(4-methylphenyl)sulfonyl]-

C13H17NO6S (315.07765420000004)


   

2-(2-CHLORO-ACETYLAMINO)-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C14H18ClNO3S (315.0695868)


   

5-BENZYLOXY-2-NITROPHENYLPYRUVIC ACID

5-BENZYLOXY-2-NITROPHENYLPYRUVIC ACID

C16H13NO6 (315.0742838)


   

TETRAAMMINEPLATINUM(II) HYDROXIDE HYDRA&

TETRAAMMINEPLATINUM(II) HYDROXIDE HYDRA&

H16N4O3Pt (315.0870196)


   

{[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

{[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

C15H13N3O3S (315.06775880000004)


   

2-(2-CHLORO-ACETYLAMINO)-6-METHYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-6-METHYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C14H18ClNO3S (315.0695868)


   

Cidofovir Dihydrate

Cidofovir Dihydrate

C8H18N3O8P (315.0831478)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors

   

Carboxy-PTIO potassium salt

Carboxy-PTIO potassium salt

C14H16KN2O4 (315.0747096)


   

4-(4-fluorophenyl)-3-[2-(4-hydroxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione

4-(4-fluorophenyl)-3-[2-(4-hydroxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione

C16H14FN3OS (315.08415660000003)


   

AZD-4635

AZD-4635

C15H11ClFN5 (315.0686968)


AZD4635 (HTL1071) is a potent, selective and orally active adenosine A2A receptor (A2AR) antagonist. AZD4635 binds to human A2AR with a Ki of 1.7 nM and shows >30-fold selectivity over other adenosine receptors[1].

   

N-((2-methyl-5-nitrophenyl)carbamothioyl)benzamide

N-((2-methyl-5-nitrophenyl)carbamothioyl)benzamide

C15H13N3O3S (315.06775880000004)


   

1-[(3,4-dimethoxyphenyl)sulfonyl]proline

1-[(3,4-dimethoxyphenyl)sulfonyl]proline

C13H17NO6S (315.07765420000004)


   

n-boc-3-chloro-d-tyrosine

n-boc-3-chloro-d-tyrosine

C14H18ClNO5 (315.0873448)


   
   

1-Methyl ethyl 2-chloro-5-[[[(1-methylethoxy)thiooxo]methyl]amino]-benzoate

1-Methyl ethyl 2-chloro-5-[[[(1-methylethoxy)thiooxo]methyl]amino]-benzoate

C14H18ClNO3S (315.0695868)


   

2,5-Dideoxy-adenosine 3-monophosphate

2,5-Dideoxy-adenosine 3-monophosphate

C10H14N5O5P (315.07325240000006)


   

(3E)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine

(3E)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine

C18H18ClNS (315.08484180000005)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

9-phenyl-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one

9-phenyl-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one

C17H17NOS2 (315.0751512)


   

diethyl [(1S)-1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl]phosphonate

diethyl [(1S)-1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl]phosphonate

C9H19ClN3O5P (315.0750804)


D000970 - Antineoplastic Agents

   

(3r)-3-Ethyl-N-[(4-Methylphenyl)sulfonyl]-L-Aspartic Acid

(3r)-3-Ethyl-N-[(4-Methylphenyl)sulfonyl]-L-Aspartic Acid

C13H17NO6S (315.07765420000004)


   

2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside

2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside

C13H15O9- (315.071604)


   

5-Hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate

5-Hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate

C13H15O9- (315.071604)


   

(3R)-3-(2,4-dimethoxyphenyl)-7-hydroxy-4-oxo-2,3-dihydrochromen-5-olate

(3R)-3-(2,4-dimethoxyphenyl)-7-hydroxy-4-oxo-2,3-dihydrochromen-5-olate

C17H15O6- (315.086859)


   

N-(1H-benzimidazol-2-yl)-2-methylsulfonylbenzamide

N-(1H-benzimidazol-2-yl)-2-methylsulfonylbenzamide

C15H13N3O3S (315.06775880000004)


   

4-(3-methylphenyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

4-(3-methylphenyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

C16H17N3S2 (315.0863842)


   

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

C15H13N3O3S (315.06775880000004)


   

4-(3-methylphenyl)-3-(5-propan-2-yl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

4-(3-methylphenyl)-3-(5-propan-2-yl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

C16H17N3S2 (315.0863842)


   

N-[(3-methoxybenzoyl)oxy]-4-nitrobenzenecarboximidamide

N-[(3-methoxybenzoyl)oxy]-4-nitrobenzenecarboximidamide

C15H13N3O5 (315.0855168)


   

3-(4-ethyl-5-methyl-3-thiophenyl)-4-(phenylmethyl)-1H-1,2,4-triazole-5-thione

3-(4-ethyl-5-methyl-3-thiophenyl)-4-(phenylmethyl)-1H-1,2,4-triazole-5-thione

C16H17N3S2 (315.0863842)


   

4-(phenylmethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

4-(phenylmethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione

C16H17N3S2 (315.0863842)


   
   

4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide

4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide

C15H13N3O3S (315.06775880000004)


   

2-Amino-3-[hydroxy-(2-hydroxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

2-Amino-3-[hydroxy-(2-hydroxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

C9H18NO9P (315.0719148)


   

hydroxyfenbendazole

hydroxyfenbendazole

C15H13N3O3S (315.06775880000004)


A member of the class of benzimidazoles that is fenbendazole in which the hydrogen at position 4 on the phenyl ring has been replaced by a hydroxy group.

   
   

(2s,3s,4r,5r)-2-{4,6-dihydroxyimidazo[4,5-d][1,2,3]triazin-5-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{4,6-dihydroxyimidazo[4,5-d][1,2,3]triazin-5-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

C10H13N5O7 (315.08149480000003)


   

1-[(2r,3r,4s,5r)-5-(1-amino-2-oxoethyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

1-[(2r,3r,4s,5r)-5-(1-amino-2-oxoethyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

C11H13N3O8 (315.0702618)


   

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid

C16H13NO6 (315.0742838)


   

6-hydroxy-3-[(2r,3r,4s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7h-imidazo[4,5-d][1,2,3]triazin-4-one

6-hydroxy-3-[(2r,3r,4s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7h-imidazo[4,5-d][1,2,3]triazin-4-one

C10H13N5O7 (315.08149480000003)


   

4-bromo-n-(5-carbamimidamidopentyl)-1h-pyrrole-2-carboxamide

4-bromo-n-(5-carbamimidamidopentyl)-1h-pyrrole-2-carboxamide

C11H18BrN5O (315.0694638)


   

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-4-hydroxybenzoic acid

2-{[(2e)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-4-hydroxybenzoic acid

C16H13NO6 (315.0742838)


   

[3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-7-ylidene](methyl)oxidanium

[3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-7-ylidene](methyl)oxidanium

[C17H15O6]+ (315.086859)


   

(2r,3r,4s,5s,6r)-2-{4,6-dihydroxyimidazo[4,5-d][1,2,3]triazin-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{4,6-dihydroxyimidazo[4,5-d][1,2,3]triazin-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

C10H13N5O7 (315.08149480000003)